Cost of Illness of the Economically Active Patients with dialysis

• Main Authors: Chieh-Yun Chen, 鄭婕筠
• Other Authors: Ming-Tien Tsai
• Format: Others
• Language: zh-TW
• Published: 2004
• Online Access: http://ndltd.ncl.edu.tw/handle/55663751805674046291

碩士 === 國立成功大學 === 高階管理碩士在職專班 === 92 === 　　This is an unprecedented study employing average life expectancy of dialysis patients to calculate the cost of illness and lifetime cost of economically active patients with end-stage renal disease in terms of society’s perspective. The mortality costs are counted as national productivity losses. Furthermore, the national expenses on direct medical costs of dialysis and the social economic cost of end-stage renal patients are respectively investigated based on prevalence and incidence rate in order to emphasize the importance of preventing renal diseases. 1. Lifetime cost of hemodialysis 　　The lifetime cost for patients in the age group 18-44 is 21.69 million NT dollars, of which 53.03 % is medical cost, 11.53 % is morbidity cost and 35.43 % corresponds to mortality cost; for the age group 45-54 the lifetime cost is 12.43 million, of which medical, morbidity and mortality costs are 49.32 %,13.08 % and 37.60 %, respectively. With regard to the age group 55-64, the lifetime cost is 5.88 million, with 78.58 % given by medical cost and 21.42 % by morbidity cost. Mortality cost is not calculated in this group. 2. Lifetime cost of peritoneal dialysis 　　The lifetime cost for patients in the age group 18-44 is 16.49 million NT dollars, of which 51.97 % is medical cost, 1.42 % is morbidity cost and 46.61 % is mortality cost; for the age group 45-54 the lifetime cost is 9.55 million, of which medical, morbidity and mortality costs are 48.71 %, 2.36 % and 48.93 %, respectively. For the age group 55-64, the lifetime cost is 3.76 million, with 94.43 % given by medical cost and 5.57 % by morbidity cost. The mortality cost is not calculated in this group. 　　The lifetime cost of end-stage renal disease is stunningly large. As a result, the prevention of renal disease becomes increasingly important. 3. Cost of illness of economically active patients with dialysis in Taiwan 　　There are totally 31,876 dialysis cases in Taiwan in 2001. Among them, 19,937 cases are economically active patients (62.55 %). 　　The total medical cost of all cases with dialysis per year is up to 212 million NT dollars. The medical cost for economically active patient is 131 million per year, with 32 millions in productivity loss per year due to morbidity, and 10 millions in productivity loss per year due to mortality. To sum up, the total costs of economically active patients with dialysis are 173 million. 　　There are 7,423 new dialysis cases in 2001. As a result there is a 49 millions increase in medical cost. The new cases with patients who are economically active are 53.29 % of all new cases. Those cases increase by 26 millions the medical cost per year, with 6 millions in productivity loss per year due to morbidity and 2 millions due to mortality. To sum up, the total cost of new cases with patients who are economically active is 34 million.